
Unraveling the Mystery of MYBPC3-Related Disorders
Discover the importance of genetic testing in diagnosing MYBPC3-related disorders like hypertrophic cardiomyopathy. Learn how it aids in treatment, family planning, and early…

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Discover the importance of genetic testing in diagnosing MYBPC3-related disorders like hypertrophic cardiomyopathy. Learn how it aids in treatment, family planning, and early…

Freeman-Sheldon syndrome, Sheldon-Hall syndrome and distal arthrogryposis types 2A and 2B share MYH3 mutations found by diagnostic, carrier or prenatal testing.

Discover the role of genetic testing in diagnosing MYH7-related disorders, including cardiomyopathy and muscular dystrophy. Learn about testing options and their benefits. (159…

Hearing and vision cells depend on myosin VIIA, so MYO7A mutations can cause Usher syndrome type 1B, non-syndromic deafness or retinitis pigmentosa.

Myocilin changes raise pressure inside the eye and underlie primary open-angle glaucoma, juvenile open-angle glaucoma and ocular hypertension.

Six genes are tied to MFM-D, including DES, CRYAB, MYOT, ZASP, FLNC and BAG3, in a disorder inherited in an autosomal dominant pattern with a 50% recurrence risk.

Passed on in an autosomal dominant way with a 50% chance to each child, NM-D stems from TPM3 mutations and brings weakness in the face, neck and limbs.

Two copies of a mutated gene, one from each parent, are needed for this congenital muscle disorder, and exome sequencing or targeted analysis can name the mutation.